Stimulatory effect of antidepressant drug pretreatment on progression of B16F10 melanoma in high-active male and female C57BL/6J mice

Journal of Neuroimmunology

Volumn 240-241, Issue , 2011, Pages 34-44

  Kubera, Marta ^a   Grygier, Beata ^a   Wrona, Danuta ^b   Rogóz, Zofia ^a   Roman, Adam ^a   Basta Kaim, Agnieszka ^a   Budziszewska, Bogusława ^a,c   Leskiewicz, Monika ^a   Jantas, Danuta ^a   Nowak, Wojciech ^d   Maes, Michael ^e   Lason, Wladyslaw ^a,d  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b UNIVERSITY OF GDA SK   (Poland)

^c JAGIELLONIAN UNIVERSITY   (Poland)

^d JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^e Piyavate Hospital   (Thailand)

Author keywords

B16F10 melanoma; Behavior; Desipramine; Fluoxetine; NK cells

Indexed keywords

DESIPRAMINE; FLUOXETINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12P40;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; FEMALE; MALE; MELANOMA; METASTASIS; MOUSE; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NONHUMAN; PRIORITY JOURNAL; SEX DIFFERENCE;

ANIMALS; ANTIDEPRESSIVE AGENTS; CELL LINE, TUMOR; CYTOKINES; CYTOTOXICITY TESTS, IMMUNOLOGIC; DESIPRAMINE; DISEASE PROGRESSION; FEMALE; FLUOXETINE; IMMUNITY, CELLULAR; KILLER CELLS, NATURAL; MALE; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; SPLEEN;

EID: 83555176364     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2011.09.006     Document Type: Article

References (57)

1. Asselin-Paturel C., Echchakir H., Carayol G., Gay F., Opolon P., Grunenwald D., Chouaib S., Mami-Chouaib F. Quantitative analysis of Th1, Th2 and TGF-beta 1 cytokine expression in tumor, TIL and PBL of non-small cell lung cancer patients. Int. J. Cancer 1998, 77:7-12.
2. Ben-Eliyahu S. The promotion of tumor metastasis by surgery and stress: immunological basis and implications for psychoneuroimmunology. Brain Behav. Immunol. 2003, 17(Suppl 1):S27-S36.
3. Ben-Eliyahu S., Yirmiya R., Liebeskind J.C., Taylor A.N., Gale R.P. Stress increases metastatic spread of a mammary tumorin rats: evidence for mediation by the immune system. Brain Behav. Immunol. 1991, 5:193-205.
4. Ben-Eliyahu S., Page G.G., Yirmiya R., Shakar G. Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity. Int. J. Cancer 1999, 80:880-888.
5. Ben-Eliyahu S., Shakhar G., Page G.G., Stefanski V., Shakhar K. Suppression of NK cell activity and of resistance to metastasis by stress: a role for adrenal catecholamines and β-adrenoceptors. Neuroimmunomodulation 2000, 8:154-164.
6. Blalock J.E., Smith E.M. Conceptual development of the immune system as a sixth sense. Brain Behav. Immunol. 2007, 21:23-33.
7. Borger P., Hoekstra Y., Esselink M.T., Postma D.S., Zaagsma J., Vellenga E., Kauffman H.F. Beta-adrenoceptor-mediated inhibition of IFN-gamma, IL-3, and GM-CSF mRNA accumulation in activated human T lymphocytes is solely mediated by the beta2-adrenoceptor subtype. Am. J. Respir. Cell Mol. Biol. 1998, 19:400-407.
8. Brunda M.J., Luistro L., Warrier R.B., Wright R.B., Hubbard B.R., Murphy M., Wolf S.F., Gately M.K. Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J. Exp. Med. 1993, 178:1223-1230.
9. Cao X., Wang Q., Ju D.W., Tao Q., Wang J. Efficient induction of local and systemic antitumor immune response by liposome-mediated intratumoral co-transfer of interleukin-2 gene and interleukin-6 gene. J. Exp. Clin. Cancer Res. 1999, 18:191-200.
10. Cloninger C.R. Temperament and personality. Curr. Opin. Neurobiol. 1994, 4:266-273.
11. Cooper A.M., Khader S.A. IL-12p40: an inherently agonistic cytokine. Trends Immunol. 2007, 28:33-38.
12. Cotterchio M., Kreiger N., Darlington G., Steingart A. Antidepressant medication use and breast cancer risk. Am. J. Epidemiol. 2000, 151:951-957.
13. Dantzer R. Cytokine-induced sickness behavior: mechanisms and implications. Ann. N. Y. Acad. Sci. 2001, 933:222-234.
14. Dellu F., Piazza P.V., Mayo W., Le Moal M., Simon H. Novelty-seeking in rats-biobehavioral characteristics and possible relationship with the sensation-seeking trait in man. Neuropsychobiology 1996, 34:136-145.
15. Dokur M., Boyadjieva N., Sarkar D.K. Catecholaminergic control of NK cell cytolytic activity regulatory factors in the spleen. J. Neuroimmunol. 2004, 151:148-157.
16. Elenkov I.J., Hasko G., Kovacs K.J., Vizi E.S. Modulation of lipopolysaccharide-induced tumor necrosis factor-alpha production by selective alpha- and beta-adrenergic drugs in mice. J. Neuroimmunol. 1995, 61:123-131.
17. Elenkov I.J., Wilder R.L., Chrousos G.P., Vizi E.S. The sympathetic nerve - an integrative interface between two supersystems: the brain and the immune system. Pharmacol. Rev. 2000, 52:595-638.
18. Grossarth-Maticek R., Eysenck H.J., Barrett P. Prediction of cancer and coronary heart disease as a function of method of questionnaire administration. Psychol. Rep. 1993, 73:943-959.
19. Grossarth-Maticek R., Eysenck H.J., Pfeifer A., Schmidt P., Koppel G. The specific action of different personality risk factors on cancer of the breast, cervix, corpus uteri and other types of cancer: a prospective investigation. Personal. Individ. Differ. 1997, 23:949-960.
20. Grundy M.A., Zhang T., Sentman C.L. NK cells rapidly remove B16F10 tumor cells in a perforin and interferon-gamma independent manner in vivo. Cancer Immunol. Immunother. 2007, 56:1153-1161.
21. Gulbinat W., Dupont A., Jablensky A., Jensen O.M., Marsella A., Nakane Y., Sartorius N. Cancer incidence of schizophrenic patients. Results of record linkage studies in three countries. Br. J. Psychiatry Suppl. 1992, 18:75-83.
22. Harning R., Koo G.C., Szalay J. Immune regulation of metastasis from in vivo derived syngeneic murine melanoma. Reg. Immunol. 1990, 1990(3):97-102.
23. Hellstrand K., Hermodsson S. An immunopharmacological analysis of adrenaline-induced suppression of human natural killer cell cytotoxicity. Int. Arch. Allergy Appl. Immunol. 1989, 89:334-341.
24. Hinojosa-Laborde C., Chapa I., Lange D., Haywood J.R. Gender differences in sympathetic nervous system regulation. Clin. Exp. Pharmacol. Physiol. 1999, 26:122-126.
25. Jin H.T., Youn J.I., Choi S.Y., Seo S.H., Park S.H., Song M.Y., Yang S.H., Sung Y.C. Adenovirus-mediated gene transfer of interleukin-23 shows prophylactic but not therapeutic antitumor effects. Cancer Gene Ther. 2008, 11:693-702.
26. Kajantie E., Phillips D.I. The effects of sex and hormonal status on the physiological response to acute psychosocial stress. Psychoneuroendocrinology 2006, 31:151-178.
27. Kubera M., Kenis G., Bosmans E., Scharpe S., Maes M. Effects of serotonin and serotonergic agonists and antagonists on the production of interferon-γ and interleukin-10. Neuropsychopharmacology 2000, 23:89-98.
28. Kubera M., Simbirtsev A., Mathison R., Maes M. The effect of repeated fluoxetine and citalopram administration to C57BL/6 mice on cytokine release. Psychiatry Res. 2000, 96:255-266.
29. Kubera M., Grygier B., Arteta B., Urbańska K., Basta-Kaim A., Budziszewska B., Leśkiewicz M., Kołaczkowska E., Maes M., Szczepanik M., Majewska M., Lasoń W. Age-dependent stimulatory effect of desipramine and fluoxetine pretreatment on metastasis formation by B16F10 melanoma in male C57BL/6 mice. Pharmacol. Rep. 2009, 61:1113-1126.
30. Lee P.P., Zeng D., McCaulay A.E., Chen Y.F., Geiler C., Umetsu D.T., Chao N.J. T helper 2-dominant antilymphoma immune response is associated with fatal outcome. Blood 1997, 90:1611-1617.
31. Lim Y.S., Kang B.Y., Kim E.J., Kim S.H., Hwang S.Y., Kim T.S. Augmentation of therapeutic antitumor immunity by B16F10 melanoma cells transfected by interferon-gamma and allogeneic MHC class I cDNAs. Moll. Cells 1998, 8:629-636.
32. Lo C.H., Lee S.C., Wu P.Y., Pan W.Y., Su J., Cheng C.W., Roffler S.R., Chiang B.L., Lee C.N., Wu C.W., Tao M.H. Antitumor and antimetastatic activity of IL-23. J. Immunol. 2003, 171:600-607.
33. Mortensen P.B. The occurrence of cancer in first admitted schizophrenic patients. Schizophr. Res. 1994, 12:185-194.
34. O'Byrne K.J., Dalgleish A.G., Browning M.J., Steward W.P., Harris A.L. The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease. Eur. J. Cancer 2000, 36:151-169.
35. O'Hara R.J., Greenman J., MacDonald A.W., Gaskell K.M., Topping K.P., Duthie G.S., Kerin M.J., Lee P.W., Monson J.R. Advanced colorectal cancer is associated with impaired interleukin 12 and enhanced interleukin 10 production. Clin. Cancer Res. 1998, 4:1943-1948.
36. Page G.G., Ben-Eliyahu S., Taylor A.N. The development of sexual dimorphism in natural killer cell activity and resistance to tumor metastasis in the Fischer 344 rat. J. Neuroimmunol. 1995, 63:69-77.
37. Page G.G., Fennelly A.M., Littleton-Kearney M.T., Ben-Eliyahu S. Male-female differences in the impact of beta-adrenoceptor stimulation on resistance to experimental metastasis: exploring the effects of age and gonadal hormone involvement. J. Neuroimmunol. 2008, 193:113-119.
38. Palermo-Neto J., Fonseca E.S., Quinteiro-Filho W.M., Correia C.S., Sakai M. Effects of individual housing on behavior and resistance to Ehrlich tumor growth in mice. Physiol. Behav. 2008, 95:435-440.
39. Penschow J., Mackay I.R. NK and K cell activity of human blood: differences according to sex, age, and disease. Ann. Rheum. Dis. 1980, 39:82-86.
40. Sajti E., Kavelaars A., van Meeteren N., Teunis M., Gispen W.H., Heijnen C. Tumor angiogenesis and metastasis formation are associated with individual differences in behavior of inbred Lewis rats. Brain Behav. Immunol. 2004, 18:497-504.
41. Sá-Rocha V.M., Sá-Rocha L.C., Palermo-Neto J. Variations in behavior, innate immunity and host resistance to B16F10 melanoma growth in mice that present social stable hierarchical ranks. Physiol. Behav. 2006, 88(1-2):108-115.
42. Shakhar G., Ben-Eliyahu S. In vivo beta-adrenergic stimulation suppresses natural killer activity and compromises resistance to tumor metastasis in rats. J. Immunol. 1998, 160:3251-3258.
43. Shingu K., Helfritz A., Kuhlmann S., Zielinska-Skowronek M., Jacobs R., Schmidt R.E., Pabst R., von Horsten S. Kinetics of the early recruitment of leukocyte subsets at the sites of tumor cells in the lungs: natural killer (NK) cells rapidly attract monocytes but not lymphocytes in the surveillance of micrometastasis. Int. J. Cancer 2002, 99:74-81.
44. Stefanski V., Ben-Eliyahu S. Social confrontation and tumor metastasis in rats: defeat and beta-adrenergic mechanisms. Physiol. Behav. 1996, 60:277-282.
45. Steingart A.B., Cotterchio M. Do antidepressants cause, promote, or inhibit cancers?. J. Clin. Epidemiol. 1995, 48:1407-1412.
46. Stepulak A., Rzeski W., Sifringer M., Brocke K., Gratopp A., Kupisz K., Turski L., Ikonomidau C. Fluoxetine inhibits the extracellular signal regulated kinase pathway and suppress growth of cancer cells. Cancer Biol. Ther. 2008, 7:1685-1693.
47. Sternbach H. Are antidepressants carcinogenic? A review of preclinical and clinical studies. J. Clin. Psychiatry 2003, 64:1153-1162.
48. Szelenyi J., Kiss J.P., Puskas E., Selmeczy Z., Szelenyi M., Vizi E.S. Opposite role of alpha2- and beta-adrenoceptors in the modulation of interleukin-10 production in endotoxaemic mice. NeuroReport 2000, 11:3565-3568.
49. Szelenyi J., Kiss J.P., Vizi E.S. Differential involvement of sympathetic nervous system and immune system in the modulation of TNF-alpha production by alpha2- and beta-adrenoceptors in mice. J. Neuroimmunol. 2000, 103:34-40.
50. Teunis M.A., Kavelaars A., Voest F., Bakker J.M., Ellenbroek B.A., Cools A.R., Heijnen C.J. Reduced tumor growth, experimental methastasis formation, and angiogenesis in rats with a hyperactive dopaminergic system. FASEB J. 2002, 16:1465-1467.
51. Teunis M.A., Heijnen C.J., Cools A.R., Kavelaars A. Reduced splenic natural killer cell activity in rats with a hyperreactive dopaminergic system. Psychoneuroendocrinology 2004, 29:1058-1064.
52. Tomiyoshi M.Y., Sakai M., Baleeiro R.B., Stankevicius D., Massoco C.O., Palermo-Neto J., Barbuto J.A. Cohabitation with a B16F10 melanoma-bearer cage mate influences behavior and dendritic cell phenotype in mice. Brain Behav. Immunol. 2009, 23:558-567.
53. Utsuyama M., Kanno J., Inoue T., Hirokawa K. Age/sex dependent and non-monotonous dose-response effect of diethylstilbestrol on the immune functions in mice. Toxicol. Lett. 2002, 135:145-153.
54. Valentino R.J., Curtis A.L., Page M.E., Pavcovich L.A., Florin-Lechner S.M. Activation of the locus ceruleus brain noradrenergic system during stress: circuitry, consequences, and regulation. Adv. Pharmacol. 1998, 42:781-784.
55. van Tits L.J., Michel M.C., Grosse-Wilde H., Happel M., Eigler F.W., Soliman A., Brodde O.E. Catecholamines increase lymphocyte b2-adrenergic receptors via a b2-adrenergic, spleen-dependent process. Am. J. Physiol. Endocrinol. Metabol. Gastrointest. Physiol. 1990, 258:E191-E202.
56. Wrona D., Trojniar W. Chronic electrical stimulation of the lateral hypothalamus increases natural killer cell cytotoxicity in rats. J. Neuroimmunol. 2003, 141:20-29.
57. Wu W., Murata J., Hayashi K., Yamaura T., Mitani N., Saiki L. Social isolation stress impairs the resistance of mice to experimental liver metastasis of murine colon 26-L5 carcinoma cells. Biol. Pharm. Bull. 2001, 24:772-776.